Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003466534 | SCV004206448 | likely pathogenic | Retinitis pigmentosa 39 | 2021-12-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003669436 | SCV004389713 | pathogenic | not provided | 2023-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp3129Glyfs*30) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (rs748200691, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV004818351 | SCV005070902 | pathogenic | Retinal dystrophy | 2019-01-01 | no assertion criteria provided | clinical testing |